1. Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy. Issue 6 (20th January 2023) Authors: Yanagisawa, Takafumi; Hata, Kenichi; Narita, Shintaro; Hatakeyama, Shingo; Mori, Keiichiro; Yata, Yuji; Sano, Takayuki; Otsuka, Takashi; Hara, Shuhei; Miyajima, Keiichiro; Enei, Yuki; Fukuokaya, Wataru; Nakazono, Minoru; Matsukawa, Akihiro; Miki, Jun; Habuchi, Tomonori; Ohyama, Chikara; Shariat, ... Journal: Prostate Issue: Volume 83:Issue 6(2023) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗